Study: New drug regimens improve outcomes for kidney transplant patients
Preliminary results from a $5.2 million clinical trial led by University of Cincinnati researchers show that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant patients without the ...
Jun 5, 2019
0
1